Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Rockwell Medical, Inc. (NASDAQ: RMTI).

Full DD Report for RMTI

You must become a subscriber to view this report.


Recent News from (NASDAQ: RMTI)

Rockwell Medical, Inc. Appoints New Vice President, Operations
WIXOM, Mich. , Dec. 10, 2018 /PRNewswire/ -- Rockwell Medical, Inc. (NASDAQ: RMTI) (the "Company" or "Rockwell Medical") today announced that Michael DeYoung has been appointed Vice President, Operations, effective immediately. Mr. DeYoung will report to Stuart Paul , President and Chi...
Source: PR Newswire
Date: December, 10 2018 08:00
Rockwell Medical Appoints New Chief Financial Officer
WIXOM, Mich. , Nov. 1, 2018 /PRNewswire/ -- Rockwell Medical, Inc. (NASDAQ:RMTI) (the "Company" or "Rockwell Medical") today announced that Angus Smith has been appointed as Chief Financial Officer of the Company, effective at the end of November 2018 . Mr. Smith will be responsib...
Source: PR Newswire
Date: November, 01 2018 08:00
Rockwell Medical Schedules Third Quarter 2018 Conference Call
WIXOM, Mich. , Oct. 29, 2018 /PRNewswire/ -- Rockwell Medical, Inc. (NASDAQ: RMTI) today announced that it will hold a conference call to discuss third quarter 2018 financial results on Friday, November 9, 2018 , at 8:30 am Eastern Time . This call is also being webcast and can ...
Source: PR Newswire
Date: October, 29 2018 08:30
Premarket analyst action - healthcare
Clovis Oncology (NASDAQ: CLVS ) resumed with Neutral rating and $33 (10% upside) price target at Piper Jaffray. Shares up  11%  premarket on Rubrace data in mCRPC. More news on: Clovis Oncology, Immunomedics, Inc., Quest Diagnostics Incorporated, Healthcare stocks news, Stocks on...
Source: SeekingAlpha
Date: October, 19 2018 08:03
Detailed Research: Economic Perspectives on Rockwell Medical, Diamondback Energy, Steven Madden, Synaptics, Photronics, and Caleres - What Drives Growth in Today's Competitive Landscape
NEW YORK, Oct. 18, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Rockwell Medical, Inc. (NASDAQ:RMTI), Diamondback Energy, Inc. (NASDAQ:FA...
Source: GlobeNewswire
Date: October, 18 2018 07:35
Rockwell Medical Announces Financing Transaction
WIXOM, Mich. , Oct. 15, 2018 /PRNewswire/ -- Rockwell Medical, Inc. (NASDAQ:RMTI) (the "Company" or "Rockwell Medical") today announced that it has agreed to sell up to 7,556,675 units to The RBI Opportunities Fund, LLC, an affiliate of Richmond Brothers, Inc. (" Richmond ") in ...
Source: PR Newswire
Date: October, 15 2018 08:00
Rockwell Medical provides update on IV Triferic
Rockwell Medical (NASDAQ: RMTI ) provides an update on the status of the development of an intravenous ("IV") formulation of proprietary drug Triferic, which is the only FDA-approved therapy indicated to replace iron and maintain hemoglobin in adult hemodialysis patients with chronic kidne...
Source: SeekingAlpha
Date: October, 12 2018 08:34
Rockwell Medical Provides Update on IV Triferic
WIXOM, Mich. , Oct. 12, 2018 /PRNewswire/ -- Rockwell Medical, Inc. (NASDAQ: RMTI) (the "Company" or "Rockwell Medical") today provided an update on the status of the Company's development of an intravenous ("IV") formulation of the Company's proprietary drug Triferic®, which is the ...
Source: PR Newswire
Date: October, 12 2018 08:00
Rockwell Medical Appoints VP, Strategic Accounts
WIXOM, Mich. , Oct. 1, 2018 /PRNewswire/ -- Rockwell Medical, Inc. (NASDAQ:RMTI) (the "Company" or "Rockwell Medical") today announced that Anne Boardman has been appointed Vice President, Strategic Accounts, effective today, October 1, 2018 . In this newly-established roll, Ms. B...
Source: PR Newswire
Date: October, 01 2018 08:00
DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Rockwell Medical, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Rockwell Medical, Inc. (“Rockwell Medical” or “the Company”) (NASDAQ: RMTI ) for violations of §§10(b) and 20(a) of...
Source: Business Wire
Date: September, 25 2018 12:14

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-084.724.584.7714.5691,697
2018-05-175.926.076.115.81205,909
2018-01-055.876.106.135.82426,548
2018-01-045.865.875.905.72333,141
2018-01-035.655.806.155.65284,364

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1426,41167,30639.2402Short
2018-12-1317,19333,25351.7036Short
2018-12-1235,48074,69747.4986Short
2018-12-1139,586105,25937.6082Short
2018-12-1031,45171,34544.0830Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on RMTI.


About Rockwell Medical, Inc. (NASDAQ: RMTI)

Logo for Rockwell Medical, Inc. (NASDAQ: RMTI)

Not available

 

Contact Information

 

 

Current Management

  • Robert L. Chioini / President, CEO
  • Thomas E. Klema / CFO, Secretary

Current Share Structure

  • Market Cap: $288,350,122 - 05/11/2018
  • Issue and Outstanding: 51,768,424 - 02/17/2018

 


Recent Filings from (NASDAQ: RMTI)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 10 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 10 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 30 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 19 2018
Preliminary proxy statement providing notification matters to be brought to a vote
Filing Type: PRE 14AFiling Source: edgar
Filing Date: April, 13 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 21 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 15 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 15 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 13 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: March, 09 2018

 

 


Daily Technical Chart for (NASDAQ: RMTI)

Daily Technical Chart for (NASDAQ: RMTI)


Stay tuned for daily updates and more on (NASDAQ: RMTI)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: RMTI)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in RMTI is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of RMTI and does not buy, sell, or trade any shares of RMTI. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/